Dr. Abdelhakeem is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224
Education & Training
- University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2018
- Ain Shams University HospitalsResidency, 2015 - 2017
- Ain Shams UniversityM.Sc., Internal Medicine, 2016
- Ain Shams University Faculty of MedicineClass of 2015
Certifications & Licensure
- FL State Medical License 2023 - 2026
- TX State Medical License 2021 - 2024
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Three biomarkers (HER2, PD-L1, and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The MD Anderson Cancer Center experience.Matheus Sewastjanow-Silva, Evan Kwiatkowski, Kohei Yamashita, Ahmed Abdelhakeem, Katsuhiro Yoshimura
International Journal of Cancer. 2024-12-15 - Immunotherapy Responses in Viral Hepatitis-Induced HCC: A Systematic Review and Meta-Analysis.Junaid Anwar, Hafiz Muhammad Arslan, Zouina Sarfraz, Juwairiya Shuroog, Ahmed Abdelhakeem
Current Oncology. 2024-11-15 - Survival Outcomes in Stage IV Gastric Cancer Patients with Krukenberg Tumors: A Systematic Review and Meta Analysis.Junaid Anwar, Ahmed Abdelhakeem, Muhammad Shariq Khan, Hafiz Muhammad Arslan, Juwairiya Shuroog
Journal of Gastrointestinal Cancer. 2024-09-01
Journal Articles
- Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with CholangiocarcinomaRikita I Hatia, Madhulika Eluri, Ernest T Hawk, Akram Shalaby, Elif Karatas, Ahmed Shalaby, Ahmed Abdelhakeem, Reham Abdel-Wahab, Ping Chang, Asif Rashid, Prasun K Jal..., Cancer Epidemiology, Biomarkers & Prevention, 10/2/2023
- Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progressionRuiping Wang, Shumei Song, Jiangjiang Qin, Katsuhiro Yoshimura, Fuduan Peng, Yanshuo Chu, Yuan Li, Yibo Fan, Jiankang Jin, Minghao Dang, Enyu Dai, Guangsheng Pei, Guan..., Cancer cell, 8/14/2023
Abstracts/Posters
- Localized diffuse-type gastric adenocarcinoma: Influence of baseline positron emission tomography on survival and therapy responseAhmed Abdelhakeem, Xuemei Wang, Rebecca E. Waters, Madhavi Patnana, Jeannelyn Estrella, Mariela A. Blum-Murphy, Allison Trail, Yang Lu, Catherine E. Devine, Naruhiko I..., Gastrointestinal Cancers Symposium, 1/15/2021
- Gallbladder disease in the absence of cirrhosis is a significant risk factor for hepatocellular carcinomaKenda Al-Assi, Rikita Hatia, Yehia Abugabal, Ahmed Abdelhakeem, Reham Abdel-Wahab , Kanwal Rghav, Prasun Jalal, AHmed Kaseb, Asif rashid, Donnghui Li, Manal hassan, The International Liver Congress 2019, Vieena, Austria, 4/10/2019
- Distribution of Insulin Growth Factor-1 (IGF-1) Binding Proteins in Hepatocellular Carcinoma With and Without Cirrhosis.Abdelhakeem, A.A. & Kaseb, A. & Hatia, A. & Ali, R. & Amin, H. & Hassan, M., J Clin Oncol, 1/1/2019
- Join now to see all
Lectures
- IGF-Child-Pugh score as a predictor of treatment outcome in advanced hepatocellular carcinoma patients treated with sorafenib.2019 ASCO Annual Meeting - 6/1/2019
- Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a c...University of Alabama at Birmingham, Birmingham, AL - 1/1/2015
Professional Memberships
- Member
- Member
- European Society for Medical OncologyMember
- Member
- Member
Other Languages
- Arabic
External Links
- LinkedInhttps://www.linkedin.com/in/aabdelhakeem/
- SciProfileshttps://sciprofiles.com/profile/abdelhakeem
- ORCIDhttps://orcid.org/0000-0001-7186-1332
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: